For the best experience, please enable JavaScript in your browser settings. Herceptin drug has been identified as counterfeit. [MoH] The Pharmacy and Poisons Board ...

Biocon recently unveiled three new biosimilar oncology assets to its R&D pipeline —trastuzumab/hyaluronidase (Herceptin ...

A regulatory decision is expected during the first quarter of 2026. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for ...

HER2-positive breast cancer, once associated with poor outcomes, now sees improved prognosis due to targeted therapies like Herceptin. Combination therapies and neoadjuvant treatments have enhanced ...

WASHINGTON A new study shows that Herceptin, a drug for breast cancer patients can also be used to lower the risk of relapse in patients with or without the gene mutation, according to published ...

The Pharmacy and Poisons Board (PPB) has cautioned the public against the use, sale, or distribution of Herceptin (Trastuzumab 440mg), circulating in the Kenyan market. Herceptin is a drug used to ...